Development of Albumin-closo -Dodecaborate Conjugates as Boron Carriers for Neutron-Capture Therapy by Ru(bpy)3 -Photocatalyzed Modification of Tyrosine

Maleimide-functionalized closo-dodecaborate albumin conjugates (MID-AC): Unique ligation at cysteine and lysine residues enables efficient boron delivery to tumor for neutron capture therapy

(2016) Shunsuke Kikuchi et al.   JOURNAL OF CONTROLLED RELEASE

Regulation of Target Protein Knockdown and Labeling Using Ligand-Directed Ru(bpy)3 Photocatalyst

(2015) Shinichi Sato et al.   BIOCONJUGATE CHEMISTRY

Ligand-Directed Selective Protein Modification Based on Local Single-Electron-Transfer Catalysis

(2013) Shinichi Sato et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Critical review, with an optimistic outlook, on Boron Neutron Capture Therapy (BNCT)

(2013) Raymond L. Moss   APPLIED RADIATION AND ISOTOPES

Development of High Boron Content Liposomes and Their Promising Antitumor Effect for Neutron Capture Therapy of Cancers

(2012) Hayato Koganei et al.   BIOCONJUGATE CHEMISTRY

Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer

(2012) Rolf F Barth et al.   Radiation Oncology

Design and synthesis of fluorescence-labeled closo-dodecaborate lipid: its liposome formation and in vivo imaging targeting of tumors for boronneutron capture therapy

(2011) Hiroyuki Nakamura et al.   ORGANIC & BIOMOLECULAR CHEMISTRY

Dodecaborate lipid liposomes as new vehicles for boron delivery system of neutron capture therapy

(2010) Manabu Ueno et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Boron neutron capture therapy for glioblastoma

(2008) Tetsuya Yamamoto et al.   CANCER LETTERS